Anti‐fibrotic actions of relaxin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti‐fibrotic actions of relaxin

Published:2016-07-07 Issue:10 Volume:174 Page:962-976
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Samuel C S¹,Royce S G¹,Hewitson T D²,Denton K M³,Cooney T E⁴,Bennett R G⁵⁶

Affiliation:

1. Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology Monash University Melbourne Vic. Australia

2. Department of Nephrology Royal Melbourne Hospital Melbourne Vic. Australia

3. Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Physiology Monash University Melbourne Vic. Australia

4. University of Pittsburgh Medical Centre (UPMC) Hamot Erie PA USA

5. Research Service 151 VA Nebraska‐Western Iowa Health Care System Omaha NE USA

6. Department of Internal Medicine University of Nebraska Medical Center Omaha NE USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.13529

Reference157 articles.

1. The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors

2. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors

3. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

4. The Concise Guide to PHARMACOLOGY 2015/16: Overview

5. Relaxin as a natural agent for vascular health

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of relaxin or relaxin mimetics in managing cardiovascular complications of diabetes;Biochemical Pharmacology;2024-11

2. Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology;Biochemical Pharmacology;2024-09

3. Rat Shoulder Contracture Models: Techniques, Evaluation, Pathophysiology, and Applications in Developing Treatment Interventions;Heliyon;2024-09

4. Engineering and Characterization of a Long-Half-Life Relaxin Receptor RXFP1 Agonist;Molecular Pharmaceutics;2024-08-12

5. Relaxin as a treatment for musculoskeletal fibrosis: What we know and future directions;Biochemical Pharmacology;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3